Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

American Journal of Psychiatry

Topics

Economics

Pathology

Medicine

Internal Medicine

Emergency Medicine

Show all topics

DOI

10.1176/appi.ajp.2018.17060720